Advaxis

Advaxis is a clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology that uses live attenuated bacteria, bioengineered to secrete antigen/adjuvant fusion proteins, with the aim of directing the robust immune response everyone has to this bacterium against cancer itself.